Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

U.S. News

Investigators Might Examine Pricing Practices of Pharmacies That Sold AIDS-Related Drug Serostim, Court Papers Suggest

October 19, 2005

Pharmacies that sold Swiss biotechnology company Serono's drug Serostim, which is used to treat AIDS-related wasting, might face federal inquiries, court papers suggest, the Boston Globe reports (Kerber, Boston Globe, 10/19). Serono on Monday agreed to pay $704 million to settle a Department of Justice investigation into the company's sales and pricing practices of the drug (Kaiser Daily HIV/AIDS Report, 10/18). Three suits filed by former Serono workers alleging wrongdoing were unsealed on Monday as a result of the settlement. According to the documents, private lawsuits have been filed against Serono that question some pharmacies' sales practices. According to one of the suits, Serono provided the drug to some unnamed parties, "apparently pharmacies," at discounts of up to roughly 4%, the Globe reports. The pharmacies allegedly then sold the drug at its regular price, and Serono allowed the pharmacies to keep the difference, a practice that could be a breach of federal drug pricing rules. The documents do not name the pharmacies involved. Assistant U.S. Attorney Mary Beth Carmody said "the allegations against Serono are resolved by the global settlement," and DOJ said its investigation into the marketing practices for Serostim is continuing. A Serono spokesperson referred to a statement released Monday by the company's general counsel that said the settlement concludes the investigation, the Globe reports (Boston Globe, 10/19).

Back to other news for October 19, 2005


Reprinted with permission from kaisernetwork.org. You can view the entire Kaiser Daily HIV/AIDS Report, search the archives, or sign up for email delivery at www.kaisernetwork.org/dailyreports/hiv. The Kaiser Daily HIV/AIDS Report is published for kaisernetwork.org, a free service of the Kaiser Family Foundation, by The Advisory Board Company. © 2005 by The Advisory Board Company and Kaiser Family Foundation. All rights reserved.



  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily HIV/AIDS Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
 
See Also
More HIV News
Advertisement:
Find out how a Walgreens specially trained pharmacist can help you

Tools
 

Advertisement